An incretin platform is a drug development framework targeting hormones like GLP-1 and GIP to regulate blood sugar and appetite. It is used to create therapies for type 2 diabetes and obesity, often as combination treatments. Patients benefit from improved glycemic control and weight loss, while researchers leverage it to design next-generation metabolic disease drugs.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends